Related Experiment Video

Updated: Jul 7, 2026

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus (MRSA) in Rat
07:46

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus (MRSA) in Rat

Published on: June 4, 2012

Methicillin-resistant versus methicillin-sensitive Staphylococcus aureus infective endocarditis

E E Hill1, W E Peetermans, S Vanderschueren

  • 1Department of Internal Medicine-Infectious Diseases, K.U. Leuven, University Hospital Gasthuisberg, Leuven, Belgium.

European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|January 29, 2008
PubMed

Insights

Methicillin-resistant Staphylococcus aureus (MRSA) infective endocarditis (IE) has higher mortality than methicillin-sensitive S. aureus (MSSA) IE. Early MRSA-active antimicrobial therapy is crucial for high-risk patients, while MSSA IE may be managed with antimicrobial therapy alone.

Area of Science:

  • Infectious Diseases
  • Cardiology
  • Clinical Microbiology

Background:

  • The incidence of methicillin-resistant Staphylococcus aureus (MRSA) infective endocarditis (IE) is rising globally.
  • Staphylococcus aureus IE presents a significant clinical challenge, with varying outcomes based on antibiotic susceptibility.

Purpose of the Study:

  • To compare clinical characteristics and mortality between MRSA IE and methicillin-sensitive S. aureus (MSSA) IE.
  • To identify factors associated with MRSA IE and inform treatment strategies.

Main Methods:

  • A prospective study of 72 consecutive patients with definite S. aureus IE (June 2000-December 2006).
  • Comparison of clinical data and outcomes between MRSA and MSSA IE groups.
  • Analysis of factors associated with MRSA and treatment modalities.

Main Results:

  • MRSA accounted for 22% of S. aureus IE cases.
  • Nosocomial origin, surgical site infection, recent surgery, catheter presence, and persistent bacteremia were linked to MRSA.
  • MSSA IE patients experienced more major embolisms and unknown bacteremia origins.
  • MRSA IE had higher 6-month mortality than MSSA IE.
  • Combined surgical and antimicrobial therapy showed the lowest mortality in MRSA IE patients.

Conclusions:

  • In S. aureus IE patients with risk factors like nosocomial origin, catheter use, or recent surgery, initial therapy should include MRSA-active agents.
  • Antimicrobial therapy alone is acceptable for selected MSSA IE patients with close monitoring.
  • Delaying or denying surgery in eligible IE patients is associated with poor prognosis.

More Related Videos

An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues07:50

An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues

Published on: January 7, 2019

Related Concept Videos

Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...